miR-31 and miR-145 as Potential Non-Invasive Regulatory\nBiomarkers in Patients with Endometriosis

Oranous Bashti, Mehrdad Noruzinia, Masoud Garshasbi, Morteza Abtahi
Cell journal · 2018 · doi:10.22074/cellj.2018.5850 · PMID:29633787 · PMC5893303 · W4404393374
article OA: gold CC0 ⤵ 16 in-corpus citations
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-11 ⓘ

This study investigated miR-31 and miR-145 as potential non-invasive regulatory biomarkers in patients diagnosed with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text ⓘ

This study evaluated whether circulating microRNAs miR-31 and miR-145 could serve as non-invasive regulatory biomarkers in patients with endometriosis, using a case–control design and measuring microRNA levels in patient samples. The authors reported differences in the expression of these microRNAs between endometriosis patients and comparison subjects, supporting their potential as biomarker candidates. The paper’s main caveat is that biomarker evaluation was based on the measured circulating levels in the sampled population without broader external validation or additional mechanistic confirmation. This paper is centrally about endometriosis — it focuses specifically on miR-31 and miR-145 as non-invasive regulatory biomarkers in endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 745 characters · extracted from oa-html · click to expand
Cell Journal (Apr 2018) miR-31 and miR-145 as Potential Non-Invasive Regulatory Biomarkers in Patients with Endometriosis - Oranous Bashti, - Mehrdad Noruzinia, - Masoud Garshasbi, - Morteza Abtahi Affiliations - Oranous Bashti - Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran - Mehrdad Noruzinia - Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran - Masoud Garshasbi - Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran - Morteza Abtahi - Dena Hospital, Shiraz, Iran - DOI - https://doi.org/10.22074/cellj.2018.5850 - Journal volume & issue - Vol. 20, no. 2 pp. 293 – 293 WeChat QR code

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (16)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:19:49.066213+00:00
License: CC0 · commercial use OK